Impact of Cumulative Social Disadvantage on Disease Severity in JIA

Overview

This study investigates the relationship between cumulative social disadvantage and disease severity in children with juvenile idiopathic arthritis (JIA). Findings indicate that higher levels of social disadvantage are associated with increased disease activity.

Background

Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic disease in children. Understanding the impact of social determinants of health (SDOH) is crucial, as they can significantly influence disease outcomes and health disparities in this population. This study aims to explore the interplay of individual, family, and community-level SDOH on disease activity in JIA.

Data Highlights

No specific numerical data or trial data provided in the source material.

Key Findings

• Cumulative social disadvantage is associated with active JIA in a large cohort.
• The effect of neighborhood-level deprivation is mediated by individual- and family-level SDOH.
• This study evaluates SDOH across multiple socioecological levels in JIA.
• Higher exposure to cumulative social disadvantage correlates with increased disease activity over time.
• Multilevel interventions may be necessary to address health disparities in JIA.

Clinical Implications

Healthcare providers should consider the impact of social determinants of health when assessing and managing children with JIA.

Conclusion

Cumulative social disadvantage influences disease severity in JIA.

Related Resources & Content

1. Soulsby et al., Arthritis Care & Research, 2023 -- Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study
2. American College of Rheumatology, ACR Releases Updated Juvenile Idiopathic Arthritis Guidelines, 2026 -- Updated guidelines for treatment of juvenile idiopathic arthritis
3. Clinical Rheumatology — Application of Biologic Therapies in Patients with Juvenile Idiopathic Arthritis Attending an Adult Rheumatology Clinic: Insights from the HUR-BIO Biologic Registry
4. Arthritis Care & Research — Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis
5. Clinical Rheumatology — Global Perspectives on Rheumatoid Arthritis Across Different Age Groups: The Impact of Onset Age on Clinical Manifestations
6. Frontiers in Pediatrics — Impact of high disease activity on damage accrual and disease outcomes in childhood-onset systemic lupus erythematosus
7. ACR Releases Updated Juvenile Idiopathic Arthritis Guidelines | American College of Rheumatology
8. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis | New England Journal of Medicine
9. Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study - Soulsby - Arthritis Care & Research - Wiley Online Library